Advertisement
Advertisement
TNYA
Tenaya Therapeutics, Inc. Common Stock
0.73
USDSponsored
0.00
+0.67%
Jun 24, 16:00 UTC -4
Closed
Pre-Market
0.72
-0.01
-1.22%
TNYA Earnings Reports
Positive Surprise Ratio
TNYA beat 14 of 20 last estimates.
70%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$10.20M
/-$0.06
Implied change from Q1 26 (Revenue/ EPS)
+4433.33%
/-33.33%
Implied change from Q2 25 (Revenue/ EPS)
--
/-57.14%
Tenaya Therapeutics, Inc. Common Stock earnings per share and revenue
On May 06, 2026, TNYA reported earnings of -0.09 USD per share (EPS) for Q1 26, missing the estimate of -0.08 USD, resulting in a -1.24% surprise. Revenue reached 225.00 thousand, compared to an expected 10.20 million, with a -97.79% difference. The market reacted with a +7.37% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.06 USD, with revenue projected to reach 10.20 million USD, implying an decrease of -33.33% EPS, and increase of 4433.33% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
What were Tenaya Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Tenaya Therapeutics, Inc. Common Stock reported EPS of -$0.09, missing estimates by -1.24%, and revenue of $225.00K, -97.79% below expectations.
How did the market react to Tenaya Therapeutics, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 7.37%, changed from $0.79 before the earnings release to $0.85 the day after.
When is Tenaya Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Tenaya Therapeutics, Inc. Common Stock's next earnings report?
Based on --
analysts, Tenaya Therapeutics, Inc. Common Stock is expected to report EPS of -$0.06 and revenue of $10.20M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement